Is Cuvitru covered by Medicare?
Cuvitru is an intravenous immunoglobulin (IVIG) product. Whether it is covered under Medicare depends on (1) the patient’s diagnosis and medical necessity and (2) whether Cuvitru is billed as part of an infusion service under a Medicare benefit category versus being handled under a pharmacy benefit.
In practice, Cuvitru coverage is often determined through Medicare’s rules for medically necessary IVIG for immunodeficiency and related conditions, plus the way the provider bills the infusion (and the setting where it is given).
What Medicare parts usually apply to Cuvitru (medical vs pharmacy)?
Medicare coverage can involve different “buckets,” which affects how Cuvitru is paid for:
- Medicare Part B commonly applies to drugs administered in an outpatient setting or during physician-administered services (often bundled with infusion/administration billing).
- Medicare Part D generally applies to prescription drugs when they are covered under the plan’s formulary and dispensed through a pharmacy.
Because IVIG is used in infusion settings, many cases are handled under Part B billing patterns, but coverage and patient cost-sharing can still differ depending on the site of service and the billing method.
What conditions make IVIG (and Cuvitru) more likely to be covered?
Medicare coverage for IVIG typically hinges on meeting Medicare and plan medical-necessity requirements for specific indications (for example, primary immunodeficiency disorders or certain immune-mediated conditions). If the prescribing diagnosis is not an accepted/covered indication under Medicare’s rules, coverage is less likely or may require additional documentation.
What do patients usually pay out of pocket under Medicare?
Your cost depends on:
- Which Medicare part covers the administration (Part B vs Part D).
- Whether the drug is covered as a Part B drug (with Part B coinsurance/deductible rules) or through Part D (with formulary tiers, copays, and deductibles).
- Whether you’re in Original Medicare or a Medicare Advantage plan (Advantage plans follow Part B drug coverage in different ways and may add plan-level rules).
How to check coverage quickly (the practical steps)
- Confirm whether Cuvitru is being billed through Part B (infusion/office/outpatient administration) or Part D (pharmacy dispensing).
- Ask the treating provider’s billing office to verify Medicare coverage for IVIG for your specific diagnosis and place of service.
- If it’s Part D, check your plan’s formulary and the specific NDC/strength the pharmacy will dispense.
- Request a prior authorization if your plan or provider requires it for IVIG.
If you share your Medicare type (Original vs Advantage), the site of care (home infusion, hospital outpatient, clinic, or pharmacy-dispensed), and the diagnosis your prescriber is using, I can help you map which Medicare pathway is most likely and what to ask for.
Source
No DrugPatentWatch.com citation was included because the information you provided asks about Medicare coverage rather than patents/exclusivity.